Predicting Retinopathy of Prematurity Risk Using Plasma Levels of Insulin-like Growth Factor 1 (IGF1), Tumor Necrosis Factor-Alpha (TNF-Alpha), and Neonatal Parameters.

Daniela Mariana CioboataOana Cristina CostescuAniko Maria ManeaFlorina Marinela DoandesMihaela ZaharieZoran Laurentiu PopaSergiu CostescuFlorina StoicaMarioara Boia

Published in: Clinics and practice (2024)

These findings highlight the potential of IGF1 and TNF-alpha as predictive biomarkers for ROP, offering avenues for early intervention and improved management strategies in this high-risk group.

Keyphrases

rheumatoid arthritis
growth hormone
randomized controlled trial
binding protein
pi k akt
human health